Table 5 Comparison of Outcome in Blood Level of Growth Factors between the Diabetic Groups.
| Â | Normal Vs DM (G1 vs G2) | ||
|---|---|---|---|
G1 vs G2 | VEGF (2nd OP) | 25.5 ± 1.9 Vs 23.9 ± 2.7 (−1.1–4.3) | 0.212 |
VEGF (2nd injection) | 23.1 ± 2.4 Vs 23.9 ± 2.3 (−3.5–1.9) | 0.522 | |
VEGF (sacrifice) | 27.6 ± 2.2 Vs 26.6 ± 2.7 (−1.8–3.9) | 0.456 | |
FGF (2nd OP) | 1149.7 ± 324.0 Vs 991.2 ± 267.4 (−187.5–504.4) | 0.338 | |
FGF (2nd injection) | 840.1 ± 228.5 Vs 839.6 ± 161.8 (−230.1–231.0) | 0.848 | |
FGF (sacrifice) | 1150.7 ± 187.4 Vs 982.5 ± 216.5 (−67.6–404.0) | 0.146 | |
IGF (2nd OP) | 347.0 ± 70.8 Vs 323.7 ± 70.6 (−59.1–105.6) | 0.655 | |
IGF (2nd injection) | 369.6 ± 16.3 Vs 273.2 ± 20.4 (75.0–117.9) |  < 0.001 | |
IGF (sacrifice) | 379.4 ± 9.0 Vs 239.0 ± 56.9 (87.7–193.1) | 0.002 | |
One−way ANOVA or Kruskal–Wallis testing P < 0.05 | Among DM (G2 ~ 4) | ||
|---|---|---|---|
VEGF (sacrifice) P = 0.002 | G 2 Vs G 3 | 26.6 ± 2.7 Vs 28.8 ± 2.6 (−5.2–0.9) | 0.048 |
G 2 Vs G 4 | 26.6 ± 2.7 Vs 39.1 ± 39.1 ± 7.7 (−19.7–(−5.3)) | 0.004 | |
G 3 Vs G 4 | 28.8 ± 2.6 Vs 39.1 ± 7.7 (−17.5–(−3.2)) | 0.006 | |
FGF (2nd injection) P = 0.005 | G 2 Vs G 3 | 839.6 ± 161.8 Vs 1161.4 ± 197.8 (−532.2–(−111.4)) | 0.007 |
G 2 Vs G 4 | 839.6 ± 161.8 Vs 897.1 ± 146.1 (−237.0–122.0) | 1.000 | |
G 3 Vs G 4 | 1161.4 ± 197.8 Vs 897.1 ± 146.1 (61.8–466.8) | 0.028 | |
FGF (sacrifice) P = 0.006 | G 2 Vs G 3 | 982.5 ± 216.5 Vs 1164.8 ± 210.7 (−431.2–66.4) | 0.723 |
G 2 Vs G 4 | 982.5 ± 216.5 Vs 1532.4 ± 382.2 (−911.7–(−188.2)) | 0.005 | |
G 3 Vs G 4 | 1164.8 ± 210.7 Vs 1532.4 ± 382.2 (−727–(−8.2)) | 0.075 | |